Background {#Sec1}
==========

Lumbar spinal stenosis (LSS) is the one of the most commonly encountered orthopedic disorders. Family doctors in the primary care setting may perform medical examinations of patients with LSS. Therefore, an understanding of the pathological mechanisms of LSS may be very helpful for these doctors.

LSS is defined as a reduction in the area of the spinal canal, lateral canal, and/or foramina. Symptoms of LSS may occur as a result of neurovascular mechanisms \[[@CR1]--[@CR3]\], such as reduced arterial flow in the cauda equina, venous congestion, increased epidural pressure, nerve root infiltration, and direct compression in the central canal and/or lateral recess \[[@CR4]\]. Although the characteristic symptom of LSS is neurogenic intermittent claudication (NIC) \[[@CR5], [@CR6]\], other symptoms may appear as well, including low back pain (LBP), radicular pain and/or numbness down the leg, and motor weakness in the legs \[[@CR7]--[@CR10]\]. It is therefore important to analyze the pathological mechanisms of LBP and/or leg pain caused by LSS to alleviate the symptoms.

We considered the pain mechanisms according to a classification that included neuropathic pain, nociceptive pain, and mixed pain \[[@CR11], [@CR12]\]. Neuropathic pain is defined by the International Association for the Study of Pain as "pain initiated or caused by a primary lesion or dysfunction of the nervous system" \[[@CR13]\]. It may be associated with abnormal sensations called dysesthesia or produced by normally nonpainful stimuli such as allodynia. Nociceptive pain may also be a result of the encoding and processing of harmful stimuli in the nervous system, reflecting the ability of the body to sense potential harm \[[@CR14]\]. Because the developmental mechanisms responsible for neuropathic and nociceptive pain differ, treatment plans differ as well. Therefore, the pathological mechanisms of the pain should be precisely identified to arrive at an exact diagnosis of LSS-derived LBP and/or leg pain.

A recent study using the painDETECT questionnaire demonstrated that neuropathic pain was less common in patients with chronic LBP and that patients with neuropathic back and/or leg pain reported significantly more pain, disability, anxiety, depression, and reduced quality of life (QOL) than patients with nociceptive pain \[[@CR15]\]. The pathological mechanisms of LSS, however, were unclear. Few studies have used the painDETECT questionnaire to quantify the pathological mechanisms of LSS \[[@CR16], [@CR17]\]. The purpose of this study was to quantify the pathological mechanisms of LBP and/or leg pain caused by LSS using the painDETECT questionnaire, and to report quality of life data in patients with LSS. This study may help to fully elucidate the epidemiology of LSS-derived LBP and/or leg pain in the primary care setting.

Methods {#Sec2}
=======

The ethics committees of the participating research institutions approved this study. Written informed consent was obtained from all patients prior to their participation.

This cross-sectional multicenter observational study was conducted nationwide at two hospitals with their attending spinal surgeons. The recruitment period was 1.5 years (1 April 2013 to 30 September 2014).

Patients {#Sec3}
--------

The study group included 102 consecutive patients (37 men, 65 women) who were newly diagnosed with LSS at two facilities: Aizu Medical Center Fukushima Medical University and the Fukushima Prefectural Minami-Aizu Hospital. Three spinal surgeons diagnosed the patients with LSS based on magnetic resonance imaging (MRI) findings of LSS, subjective symptoms, and neurological findings. All of the patients had subjective symptoms that included leg symptoms, LSS-related neurological findings, and MRI evidence of LSS. An independent radiologist assessed the MRI scans obtained for each patient at the time of diagnosis for evidence of LSS, including central, lateral recess, and foraminal stenosis. The MRI diagnosis of LSS was based on the following findings: (1) blockage of cerebrospinal fluid and/or the disappearance of fatty tissue surrounding the foramen on T1-weighted images in the sagittal view; (2) central stenosis, lateral recess stenosis, and/or foraminal stenosis caused by lumbar disc compression from the front, and/or increased size of the ligamentum flavum, and/or articular factors from the back in the axial view; and/or (3) compression of the nerve root surrounding the foramen in the coronal view. The ankle-brachial pressure index (ABI) was also checked in all patients to distinguish NIC from vascular intermittent claudication (ABI \<0.9). The ABI is the systolic pressure at the ankle divided by the systolic pressure at the arm. It has been shown to be a specific and sensitive metric for the diagnosis of peripheral arterial disease \[[@CR18]\].

The inclusion criteria for all patients were (1) a diagnosis of lumbar spondylosis, degenerative spondylolisthesis, or degenerative scoliosis with LSS; (2) pain and/or numbness in the lumbar dermatomal distribution; (3) motor or sensory neurological signs (hypoesthesia, hyperesthesia, allodynia, or dysesthesia) in the affected dermatomes; (4) cognitive capability to satisfy our inquiries; and (5) neurogenic NIC due to LSS. The exclusion criteria for all patients were (1) diagnosis of lumbar degenerative disease without LSS; (2) predominantly axial spinal pain; (3) rheumatoid arthritis; (4) known peripheral neuropathy; (5) history of workmen's compensation or disability issues; (6) chronic depression and use of antidepressant medication; and (7) patients with an ABI of \<0.9.

Methods {#Sec4}
-------

The painDETECT neuropathic pain screening questionnaire scores \[[@CR17]\] were used to identify the three pain subgroups of patients with LBP and/or leg pain caused by LSS: (1) those with nociceptive pain, (2) those with neuropathic pain, and (3) those in whom the type of pain was unclear \[[@CR15], [@CR19]\]. We used the Japanese version of the painDETECT neuropathic pain screening questionnaire score \[[@CR20]\]. The cut-off values for categorizing the type of pain based on the painDETECT neuropathic pain screening questionnaire scores were as follows: nociceptive pain, 0--12; unclear type of pain (mixed nociceptive and neuropathic pain), 13--18; and neuropathic pain, 19--38. The painDETECT neuropathic pain screening questionnaire is a reliable screening tool with high sensitivity, high specificity, and positive predictive accuracy. These parameters were each 84 % in a palm-top computerized version of the questionnaire and 85, 80, and 83 %, respectively, in a corresponding pencil-and-paper questionnaire \[[@CR17]\]. Matsubayashi et al. \[[@CR20]\] demonstrated that the Japanese version of the painDETECT neuropathic pain screening questionnaire has good validity and reliability, similar to that found with the original version.

Numerical rating scale (NRS) and Roland-Morris Disability Questionnaire (RDQ) scores \[[@CR21]\] were used to compare the severity of subjective symptoms and the QOL associated with LBP at the patient's first medical examination. The patients used the NRS for self-evaluation of their leg pain and/or numbness. Both the NRS and RDQ scores were evaluated at the time of the first medical examination. We used the Japanese version of the RDQ score \[[@CR22]\].

The Japanese Orthopaedic Association Back Pain Evaluation Questionnaire (JOABPEQ) \[[@CR23], [@CR24]\] and the 36-Item Short-Form Health Survey (SF-36) \[[@CR25]\] were used to compare the severity of subjective symptoms and the QOL associated with LBP and health at the patient's first medical examination. The JOABPEQ has five subscales, and the SF-36 has eight. For both questionnaires, higher scores indicate better QOL. We used the Japanese version of the SF-36 \[[@CR26], [@CR27]\]. The SF-36 uses scores of 0 to 100, but the scores are not based on the norm.

The primary outcome was the type of pain---nociceptive, neuropathic, or unclear (mixed)---in patients with LBP and/or leg pain caused by LSS. At the first medical examination, we compared the patients' demographic and clinical characteristics; NRS (LBP); NRS (leg pain, leg numbness); and RDQ, JOABPEQ, and SF-36 scores among the three pain groups using the Kruskal--Wallis test. We also compared these outcomes according to the duration of symptoms---i.e., \<3 months (acute and/or subacute phase) or ≥3 months (chronic phase) after the onset of LBP and/or leg pain caused by LSS. A *p* value of \<0.05 was considered to indicate statistical significance. The statistical analyses were performed using StatView 5.0 statistical software (SAS Institute, Cary, NC, USA). The statistical power analysis of this study was performed using G\*Power 3.1 (Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany) \[[@CR28]\]. The power analysis utilized an effect size of 0.4, alpha level of 0.05, power (1 − beta error probability) of 0.95, and requirement of three groups. Finally, the total required sample size was calculated as 102.

Ethics {#Sec5}
------

This study was approved by the ethics committees of the two participating research institutions: Aizu Medical Center Fukushima Medical University and Fukushima Prefectural Minami-Aizu Hospital. Informed consent was obtained from all patients.

Results {#Sec6}
=======

The mean age of all patients (*n* = 102) in this study was 70.3 ± 2 years. The male:female distribution was 37:65 (36.3:63.7 %). The NIC was radicular in 68.6 % (*n* = 70), caudal in 8.8 % (*n* = 9), and mixed in 22.6 % (*n* = 23). Spinal stenosis seen by MRI appeared at one level in 41.4 % (*n* = 42), two levels in 43.1 % (*n* = 44), and three levels in 11.7 % (*n* = 12). The causes of LSS were lumbar spondylitis in 55.0 % (*n* = 56), degenerative spondylolisthesis in 33.3 % (*n* = 34), and degenerative scoliosis in 11.7 % (*n* = 12).

The demographic and clinical characteristics of the patients with LBP and/or leg pain caused by LSS for each pain subgroup are shown in Table [1](#Tab1){ref-type="table"}. The demographic and clinical characteristics of the patients with LBP and/or leg pain caused by LSS were similar among the three pain subgroups.Table 1Demographic and clinical characteristics at the first medical examinationCharacteristicNociceptive painType of pain unclear (mixed pain)Neuropathic pain*p* ^a^Age (years)71.4 ± 1.3669.0 ± 2.3468.3 ± 2.910.720Sex0.572 Male18118 Female411410Duration of pain0.914 ≧3 months411714 \<3 months1884Affected spinal level0.730 L3--L41893 L4--L5361615 L5--S1500NIC type0.668 Radicular411514 Caudal540 Mixed1364Spinal stenosis levels involved^b^0.373 12886 225118 ≥3664Cause of LSS0.672 Lumbar spondylitis301511  Degenerative spondylolisthesis2086 Degenerative scoliosis921The demographic and clinical characteristics of the patients with LBP and/or leg pain caused by LSS were similar among the three pain subgroups*LBP* low back pain, *LSS* lumbar spinal stenosis, *NIC* neurogenic intermittent claudication, *LDH* lumbar disc degeneration, *MRI* magnetic resonance imaging^a^Kruskal--Wallis test^b^Seen on MRI

Among all patients with LBP and/or leg pain caused by LSS, 59 (57.9 %) had nociceptive pain, 18 (17.6 %) had neuropathic pain, and 25 (24.5 %) had an unclear type of pain (mixed pain) at their first medical examination (Table [2](#Tab2){ref-type="table"}). In all, 72 (70.6 %) patients had chronic pain (duration of ≥3 months), and 30 (29.4 %) had subacute or acute pain (duration of \<3 months). Among the patients whose LBP and/or leg pain caused by LSS had been present for ≥3 months, 41 (56.9 %) had nociceptive pain, 14 (19.5 %) had neuropathic pain, and 17 (23.6 %) had pain of unclear (mixed pain) at their first medical examination (Table [2](#Tab2){ref-type="table"}). Among those whose LBP and/or leg pain caused by LSS had been present for \<3 months, 18 (60.0 %) patients had nociceptive pain, 4 (13.3 %) had neuropathic pain, and 8 (26.7 %) had unclear pain (mixed pain) at their first medical examination (Table [2](#Tab2){ref-type="table"}). The populations of the three pain subgroups \[nociceptive, neuropathic, and unclear (mixed)\] with LBP and/or leg symptoms caused by LSS (regardless of pain duration) were thus similar.Table 2painDETECT questionnaire scores at the first medical examinationOrigin of painPatients, n (%)Total patients102 (100) Nociceptive pain59 (57.9) Type of pain unclear (mixed pain)25 (24.5) Neuropathic pain18 (17.6)Group with pain present ≥3 months Nociceptive pain41 (56.9) Type of pain unclear (mixed pain)17 (23.6) Neuropathic pain14 (19.5)Group with pain present \<3 months Nociceptive pain18 (60.0) Type of pain unclear (mixed pain)8 (26.7) Neuropathic pain4 (13.3)*LBP* low back pain, *LSS* lumbar spinal stenosis

NRS scores for LBP, leg pain, and leg numbness in patients with LBP and/or leg pain caused by LSS were not significantly different among the three pain groups (Table [3](#Tab3){ref-type="table"}). However, the RDQ score in patients with LBP and/or leg pain caused by LSS was significantly lower in the neuropathic pain group than in the other groups (*p* \< 0.05) (Table [3](#Tab3){ref-type="table"}). In contrast, there were no significant differences among the three pain groups regarding (1) the NRS scores for LBP, leg pain, or leg numbness or (2) the RDQ scores in patients with LBP and/or leg pain caused by LSS that had been present for ≥3 months or \<3 months (Table [3](#Tab3){ref-type="table"}).Table 3NRS and RDQ scores at the first medical examinationParameterNociceptive painType of pain unclear (mixed pain)Neuropathic pain*p* ^a^Total patients with pain at first examination NRS (low back pain)4.75 ± 0.4335.88 ± 0.5616.39 ± 0.6910.099 NRS (leg pain)5.59 ± 0.3976.72 ± 0.6186.39 ± 0.6870.205 NRS (leg numbness)4.88 ± 0.4225.56 ± 0.6516.83 ± 0.5560.101 RDQ9.00 ± 0.7609.52 ± 1.166.68 ± 1.570.025^a^Group with pain present ≥3 months NRS (low back pain)5.27 ± 0.5236.12 ± 0.5876.43 ± 0.7240.462 NRS (leg pain)5.61 ± 0.4796.35 ± 0.7226.57 ± 0.6850.566 NRS (leg numbness)5.49 ± 0.5135.82 ± 0.6666.50 ± 0.6180.713 RDQ9.66 ± 0.9528.82 ± 1.4113.7 ± 1.770.074Group with pain present \<3 months NRS (low back pain)3.56 ± 0.7155.38 ± 1.286.25 ± 2.060.275 NRS (leg pain)5.56 ± 0.7297.50 ± 1.205.75 ± 2.180.275 NRS (leg numbness)3.50 ± 0.6435.00 ± 1.528.00 ± 1.230.060 RDQ7.50 ± 1.1911.0 ± 2.0913.5 ± 3.970.125Data are shown as mean ± standard errorThe NRS scores of LBP, leg pain, and leg numbness in patients with LBP and/or leg pain caused by LSS were not significantly different among the three pain groups. However, the RDQ score in patients with LBP and/or leg pain caused by LSS was significantly lower in the neuropathic pain group than in the other groups (*p* \< 0.05)*NRS* numerical rating scale, *RDQ* Roland--Morris Disability Questionnaire^a^Kruskal--Wallis test

The five JOABPEQ subscales were LBP, lumbar function, walking ability, social life function, and mental health. The eight SF-36 subscales were physical functioning, physical role functioning, bodily pain, general health perceptions, vitality, emotional functioning, social role functioning, and mental health. The subscale scores of both questionnaires for each pain group are shown in Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}. There were statistically significant differences in three JOABPEQ subscales \[lumbar function, social life function, and mental health (*p* \< 0.05)\] and in two SF-36 subscales \[physical function and bodily pain (*p* \< 0.05)\] (Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}). In regard to pain duration, for patients whose pain had been present for ≥3 months after the onset of symptoms, there were statistically significant differences in two JOABPEQ subscales \[lumbar function and mental health (*p* \< 0.05)\], but no statistically significant differences in any of the SF-36 subscales (Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}). For patients whose pain had been present for \<3 months after the onset of symptoms, there were no statistically significant differences in any of the JOABPEQ subscales (*p* \< 0.05), but there was a statistically significant difference in one SF-36 subscale \[bodily pain (*p* \< 0.05)\] (Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}).Table 4JOABPEQ score for each pain type at the first medical examinationParameterNociceptive painType of pain unclear (mixed pain)Neuropathic pain*p* ^a^Total patients with pain at first examination Low back pain50.8 ± 4.2141.1 ± 7.3030.9 ± 6.940.071 Lumbar function66.1 ± 3.6664.9 ± 5.2937.0 ± 7.800.005^a^ Walking ability44.8 ± 4.0640.0 ± 4.3735.3 ± 6.660.580 Social life function50.6 ± 2.9936.8 ± 3.4542.8 ± 5.790.015^a^ Mental health49.4 ± 2.4740.6 ± 3.5439.8 ± 5.170.048^a^Group with pain present ≥3 months Low back pain48.1 ± 5.0741.1 ± 8.2329.6 ± 8.130.188 Lumbar function63.6 ± 4.9165.1 ± 6.8738.1 ± 8.560.033^a^ Walking ability42.6 ± 5.0439.5 ± 6.0036.7 ± 7.060.881 Social life function49.5 ± 3.9135.5 ± 4.3044.1 ± 6.790.064 Mental health52.5 ± 2.8141.1 ± 4.4240.7 ± 5.600.032^a^Group with pain present \<3 months Low back pain57.2 ± 7.5541.0 ± 15.635.8 ± 14.80.373 Lumbar function71.8 ± 4.2464.5 ± 8.4233.3 ± 20.80.172 Walking ability49.7 ± 6.8041.3 ± 5.4130.5 ± 19.10.530 Social life function53.2 ± 4.1739.5 ± 6.0438.5 ± 12.20.204 Mental health42.2 ± 4.6239.8 ± 6.2636.5 ± 14.20.869Data are shown as mean ± standard errorThe JOABPEQ comprises five subscales. Higher scores indicate better quality of lifeThere were statistically significant differences in three JOABPEQ subscale scores \[lumbar function, social life function, and mental health (*p* \< 0.05)\]. With respect to pain duration, for patients with chronic pain, there were statistically significant differences in two JOABPEQ subscale scores \[lumbar function and mental health (*p* \< 0.05)\]. For patients with subacute or acute pain, there were no statistically significant differences in any of the JOABPEQ subscale scores (*p* \< 0.05)*JOABPEQ* Japanese Orthopaedic Association Back Pain Evaluation Questionnaire^a^Kruskal--Wallis testTable 5SF-36 score for each pain type at the first medical examinationParameterNociceptive painType of pain unclear (mixed pain)Neuropathic pain*p* ^a^Total patients with pain at first examinationPhysical functioning27.0 ± 2.1430.2 ± 2.6721.1 ± 4.730.040^a^ Role physical33.8 ± 2.1534.5 ± 3.0526.5 ± 4.130.326 Bodily pain35.8 ± 0.9232.5 ± 1.6429.6 ± 2.530.011^a^ General health42.4 ± 1.2041.4 ± 1.9939.5 ± 2.870.668 Vitality46.3 ± 1.4341.6 ± 3.0144.1 ± 2.730.396 Social functioning44.3 ± 1.6640.5 ± 2.5537.0 ± 4.530.179 Role emotional40.1 ± 2.1636.5 ± 3.0932.4 ± 4.040.160 Mental health46.3 ± 1.4042.8 ± 2.6142.1 ± 3.390.287Group with pain present ≥3 monthsPhysical functioning25.5 ± 2.5828.4 ± 3.2821.9 ± 5.290.201 Role physical32.2 ± 2.8633.0 ± 4.1528.2 ± 4.610.797 Bodily pain34.9 ± 1.1130.9 ± 1.2331.4 ± 2.960.103 General health42.2 ± 1.4238.1 ± 1.8539.8 ± 3.120.318 Vitality45.1 ± 1.7238.9 ± 3.8845.0 ± 3.180.471 Social functioning44.1 ± 2.0039.7 ± 3.2439.2 ± 5.090.473 Role emotional39.0 ± 2.8835.1 ± 4.1034.6 ± 4.490.522 Mental health46.6 ± 1.7940.0 ± 3.2044.0 ± 3.640.183Group with pain present \<3 monthsPhysical functioning30.5 ± 3.8034.0 ± 4.6118.2 ± 11.90.197 Role physical37.3 ± 2.6037.9 ± 3.6920.4 ± 9.890.166 Bodily pain37.8 ± 1.5835.9 ± 4.3523.2 ± 3.550.021^a^ General health42.7 ± 2.2948.5 ± 3.8738.2 ± 7.900.335 Vitality49.2 ± 2.5347.6 ± 4.1241.0 ± 5.760.494 Social functioning44.7 ± 3.1042.3 ± 4.2629.2 ± 10.20.288 Role emotional42.7 ± 2.6839.6 ± 4.3324.7 ± 9.250.121 Mental health45.6 ± 2.1948.8 ± 3.9835.2 ± 8.490.292Data are shown as mean ± standard errorThe SF-36 comprises eight subscales (score of 0--100). Higher scores indicate better quality of lifeThere were statistically significant differences in two SF-36 subscale scores \[physical function and bodily pain (*p* \< 0.05)\]. With respect to pain duration, for patients with chronic pain, there were no statistically significant differences in any of the SF-36 subscale scores. For patients with subacute or acute pain, there was a statistically significant difference in one SF-36 subscale score \[bodily pain (*p* \< 0.05)\]*SF-36* 36-Item Short-Form Health Survey^a^Kruskal--Wallis test

Discussion {#Sec7}
==========

The present study demonstrated four major points. (1) Overall, 58 % of the 102 patients with LBP and/or leg pain caused by LSS had nociceptive pain, 18 % had neuropathic pain, and 24 % had an unclear type of pain (mixed pain) at their first medical examination. (2) NRS scores for LBP, leg pain, and leg numbness in patients with LBP and/or leg pain caused by LSS were not significantly different among the three pain groups. The RDQ score in patients with LBP and/or leg pain caused by LSS, however, was significantly lower in the neuropathic pain group than in the other groups. (3) Three JOABPEQ subscales (lumbar function, social life function, and mental health) were significantly lower in the neuropathic pain group than in the other groups. (4) Two SF-36 subscales (physical function and bodily pain) were significantly lower in the neuropathic pain group than in the other groups.

The statistical power analysis performed in this study indicated a required total sample size of 102, and the power was 0.95. Therefore, we believe that the power of this study was adequate.

LSS may occur at different levels in the spinal canal. It may be caused by entrapment of nerve roots in the cauda equina due to hypertrophy of the osseus and soft tissue structures surrounding the lumbar spinal canal. Central canal stenosis may compress nerve roots in the cauda equina, whereas lateral recess stenosis and/or foraminal stenosis may compress nerve roots but spare the spine \[[@CR29], [@CR30]\]. Although the lower limb symptoms associated with LSS are mainly attributed to mechanoreceptive compression of nerve rootlets and/or the cauda equina, they are also associated with inflammation, ischemia, malnutrition, nerve degeneration, and nerve injury. They consequently have a complicated pathophysiology. The pathological mechanisms of lower limb symptoms caused by LSS involve nociceptive, inflammatory, and/or neuropathic pain components, which may result from postural changes or persistent compression of the nerve roots and/or cauda equina while walking.

The prevalence of neuropathic pain in the general population is unclear, although it has been reported at 3--9 % based on the results of various screening questionnaires in Europe and the United States \[[@CR31]--[@CR34]\]. Few studies, however, have used the painDETECT to analyze the pathological mechanisms of LBP and/or leg pain caused by LSS in primary care-referred patients. Beith et al. \[[@CR15]\] studied patients from southeastern England who had LBP with or without leg pain and had been referred for physiotherapy. The authors reported that 59 % of the patients reported what was identified to be nociceptive pain, 16 % had neuropathic pain, and 25 % had an unclear type (mixed pain). This result is very similar to that obtained in the present study of the pathological mechanisms of LSS-derived LBP and/or leg pain (nociceptive pain, 58 %; neuropathic pain, 18 %; unclear pain (mixed pain), 24 %). Therefore, our findings may accurately elucidate the pathological mechanisms of LSS-derived LBP and/or leg pain in the primary care setting.

The NRS scores for LBP, leg pain, and leg numbness in our patients with LBP and/or leg pain caused by LSS were not significantly different among the three pain groups. However, the RDQ score, three JOABPEQ subscale scores (lumbar function, social life function, and mental health), and two SF-36 subscale scores (physical function and bodily pain) were significantly lower in the neuropathic pain group than in the other groups. These data suggest that the neuropathic pain component produced significantly lower scores than its non-neuropathic pain components and reduced the patients' physical and/or psychological QOL. Therefore, patients with neuropathic back and/or leg pain caused by LSS should be diagnosed as soon as possible after referral. A previous study \[[@CR35]\] compared JOABPEQ scores between patients with LBP who experienced either neuropathic pain or nociceptive pain as assessed by the Japanese version of the painDETECT. Their findings suggest that neuropathic pain affects the social and psychological well-being of patients with LBP and demonstrate that patients with neuropathic back and/or leg pain caused by LSS might have particularly low physical and/or psychological QOL.

Finally it is considered that the impact of this study on education, health services and research regarding primary care would suggest that it may be very important to elucidate the pathological mechanisms and the epidemiology of LSS-derived LBP and/or leg pain by classifying the patients with LSS using painDETECT in order to analyze either neuropathic pain or non-neuropathic pain, and this may be helpful to examine how to treatment for LSS-derived LBP and/or leg pain in primary care setting.

The present study has some limitations that require attention. First, we studied only a small population, although we believe that the power was adequate in this study. Future studies must plan to evaluate a larger population. Second, this study had a cross-sectional design---it was not a longitudinal study. We did not evaluate therapeutic efficacy for LSS in this study. Hence, future studies should evaluate the therapeutic efficacy for each pain group caused by LSS, including conservative versus surgical therapy. Third, it was considered the lack thorough clinical and laboratory investigation in this study, since our study utilizes only questionnaires to classify the pain introduced by LSS. A clinical study with post-licensure surveillance should be implemented, ideally by setting up a database that includes all patients seeking treatment for LBP and/or leg pain caused by LSS, minimizing losses to follow-up, and using validated methods to gather clinically relevant data including demographic information, clinical features, common co-morbidities, conservative and/or surgical treatments applied to each patient, experience and training standards of the care providers applying each treatment, and each patient's clinical evolution \[[@CR36]\].

Conclusions {#Sec8}
===========

It may be important to analyze the pathological mechanisms of neuropathic pain and non-neuropathic pain in patients with LBP and/or leg pain caused by LSS. Patients with neuropathic back and/or leg pain caused by LSS may experience particularly low physical and/or psychological QOL.
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